Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias

Annals of Surgery

Volumn 244, Issue 1, 2006, Pages 61-70

  Tonelli, Francesco ^a   Fratini, Geri ^a   Nesi, Gabriella ^a   Tommasi, Maria Silvia ^a   Batignani, Giacomo ^a   Falchetti, Alberto ^a,b   Brandi, Maria Luisa ^a,b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

SECRETIN;

ADULT; ARTICLE; CANCER SURGERY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; ENDOCRINE TUMOR; FEMALE; GASTRINOMA; HUMAN; HYPERGASTRINEMIA; INSULINOMA; MALE; PANCREAS RESECTION; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROVOCATION TEST; RECURRENT DISEASE; SURGICAL TECHNIQUE; ZOLLINGER ELLISON SYNDROME; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA; PANCREAS TUMOR;

ADULT; FEMALE; GASTRINOMA; HUMANS; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; PANCREATECTOMY; PANCREATIC NEOPLASMS; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATIONS; ZOLLINGER-ELLISON SYNDROME;

EID: 33747484920     PISSN: 00034932     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.sla.0000218073.77254.62     Document Type: Article

References (46)

1. Vasen HF, Lamers CB, Lips CJ. Screening for the multiple endocrine neoplasia syndrome type I: a study of 11 kindreds in The Netherlands. Arch Intern Med. 1989;149:2717-2722.
2. Skogseid B, Eriksson B, Lundqvist G, et al. Multiple endocrine neoplasia type 1: a 10 years prospective screening study in four kindreds. J Clin Endocrinol Metab. 1991;73:281-287.
3. Marx SJ. Multiple endocrine neoplasia type 1. In: Scriver CR, Beaudet AL, Sly WS., et al. eds. The Metabolic and Molecular Bases of Inherited Disease, 8th ed. New York: McGraw-Hill.
4. Lairmore TC, Chen VY, De Benedetti MK, et al. Duodenopancreatic resections in patients with multiple endocrine neoplasia type 1. Ann Surg. 2000;231:909-918.
5. Jensen RT. Pancreatic endocrine tumors: recent advances. Ann Oncol. 1999;10(suppl 4):170-176.
6. Pipeleers-Marichal M, Somers G, Willems G, et al. Gastrinomas in the duodenum of patients with multiple endocrine neoplasia type 1 and the Zollinger-Ellison syndrome. N Engl J Med. 1990;322:723-727.
7. Mignon M, Ruszniewski P, Podevin P, et al. Current approach to the management of gastrinoma and insulinoma in adults with multiple endocrine neoplasia type 1. World J Surg. 1993;17:489-497.
8. Lips CJ. Clinical management of the multiple endocrine neoplasia syndromes: results of a computerized opinion poll at the Sixth International Workshop on Multiple Endocrine Neoplasia and von Hippel-Lindau disease. J Intern Med. 1998;243:589-594.
9. Norton JA, Jensen RT. Unresolved surgical issues in the management of patients with Zollinger-Ellison syndrome. World J Surg. 1991;15:151-159.
10. MacFarlane MP, Fraker DL, Alexander HR, et al. Prospective study of surgical resection of duodenal and pancreatic gastrinomas in multiple endocrine neoplasia type 1. Surgery. 1995;118:973-979.
11. Gibril F, Venzon DJ, Ojeaburu JV, et al. Prospective study of the natural history of gastrinoma in patients with MEN1: definition of an aggressive and a nonaggressive form. J Clin Endocrinol Metab. 2001;86:582-593.
12. Skogseid B, Oberg K, Eriksson B, et al. Surgery for asymptomatic pancreatic lesion in multiple endocrine neoplasia type 1. World J Surg. 1996;20:872-876.
13. Thompson NW, Bondeson AG, Bondeson L, et al. The surgical treatment of gastrinoma in MEN I syndrome patients. Surgery. 1989;106:1081-1085.
14. Norton JA, Douglas LF, Alexander HR, et al. Surgery to cure the Zollinger-Ellison syndrome. N Engl J Med. 1999;341:635-644.
15. Bartsch DK, Langer P, Wild A, et al. Pancreaticoduodenal endocrine tumors in multiple endocrine neoplasia type 1: surgery or surveillance? Surgery. 2000;128:958-966.
16. Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001;86:5658-5671.
17. Morelli A, Falchetti A, Martineti V, et al. MEN1 gene mutation analysis in Italian patients with multiple endocrine neoplasia type 1 syndrome. Eur J Endocrinol. 2000;142:131-137.
18. Imamura M, Takahashi K, Isobe Y, et al. Curative resection of multiple gastrinomas aided by selective arterial secretin injection test and intraoperative secretin test. Ann Surg. 1989;210:710-718.
19. Imamura M, Takahashi K. Use of selective arterial secretin injection test to guide surgery in patients with Zollinger-Ellison syndrome. World J Surg. 1993;17:433-438.
20. Veldhuis JD, Norton JA, Wells SA Jr, et al. Surgical versus medical management of multiple endocrine neoplasia (MEN) type I. J Clin Endocrinol Metab. 1997;82:357-364.
21. Mozell E, Woltering EA, O'Dorisio TM, et al. Effect of somatostatin analog on peptide release and tumor growth in the Zollinger-Ellison syndrome. Surg Gynecol Obstet. 1990;170:476-484.
22. Kloppel G, Willemer S, Stamm B, et al. Pancreatic lesions and hormonal profile of pancreatic tumors in multiple endocrine neoplasia type I: an immunocytochemical study of nine patients. Cancer. 1986;57:1824-1832.
23. Demeure MJ, Klonoff DC, Karam JH, et al. Insulinomas associated with multiple endocrine neoplasia type I: the need for a different surgical approach. Surgery. 1991;110:998-1004.
24. O'Riordain DS, O'Brien T, van Heerden JA, et al. Surgical management of insulinoma associated with multiple endocrine neoplasia type I. World J Surg. 1994;18:488-493.
25. Norton JA, Alexander HR, Fraker DL, et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg. 2001;234:495-505.
26. Kouvaraki MA, Lee JE, Shapiro SE, et al. Genotype-phenotype analysis in multiple endocrine neoplasia type 1. Arch Surg. 2002;137:641-647.
27. Dotzenrath C, Goretzki PE, Cupisti K, et al. Malignant endocrine tumors in patients with MEN1 disease. Surgery. 2001;129:91-95.
28. Ruszniewski P, Amouyal P, Amouyal G, et al. Localization of gastrinomas by endoscopic ultrasonography in patients with Zollinger-Ellison syndrome. Surgery. 1995;117:629-635.
29. Proye C, Malvaux P, Pattou F, et al. Noninvasive imaging of insulinomas and gastrinomas with endoscopic ultrasonography and somatostatin receptor scintigraphy. Surgery. 1998;124:1134-1143.
30. Burcharth F, Stage JG, Stadil F, et al. Localization of gastrinomas by transhepatic portal catheterization and gastrin assay. Gastroenterology. 1979;77:444-450.
31. Åkerström G, Hessman O, Skogseid B. Timing and extent of surgery in symptomatic and asymptomatic neuroendocrine tumors of the pancreas in MEN1. Langenbecks Arch Surg. 2002;386:558-569.
32. Thompson NW. Surgical treatment of the endocrine pancreas and Zollinger-Ellison syndrome in the MEN1 syndrome. Henry Ford Hosp Med J. 1992;40:195-198.
33. Norton JA, Alexander HR, Fraker DL, et al. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome. Ann Surg. 2001;234:495-505.
34. Thompson NW. Current concepts in the surgical management of multiple endocrine neoplasia type 1 pancreatic-duodenal disease: results in the treatment of 40 patients with Zollinger-Ellison syndrome, hypoglycaemia or both. J Intern Med. 1998;243:495-500.
35. Delcore R, Friesen SR. Role of pancreatoduodenectomy in the management of primary duodenal wall gastrinomas in patients with Zollinger-Ellison syndrome. Surgery. 1992;112:1016-1022.
36. Stadil F. Treatment of gastrinomas with pancreatoduodenectomy. In: Mignon M, Jensen RT, eds. Endocrine Tumors of the Pancreas: Recent Advances in Research and Management, vol. 23. Frontiers of Gastrointestinal Research. Basel, Switzerland: Karger, 1995:333-341.
37. Suzuki Y, Fujino Y, Tanioka Y, et al. Selection of pancreaticojejunostomy techniques according to pancreatic texture and duct size. Arch Surg. 2002;137:1044-1047.
38. Yang YM, Tian XD, Zhuang Y, et al. Risk factors of pancreatic leakage after pancreatoduodenectomy. World J Gastroenterol. 2005;11:2456-2461.
39. Yeo CJ, Cameron JL, Lillemoe K, et al. Does prophylactic octreotide decrease the rates of pancreatic fistula and other complications after pancreatoduodenectomy? Ann Surg. 2000;232:419-429.
40. McLeod RS, Taylor BR, O'Connor BI, et al. Quality of life, nutritional status and gastrointestinal hormone profile following the Whipple procedure. Am J Surg. 1995;169:179-185.
41. Rindi G, Bordi C, Rappel S, et al. Gastric carcinoids and neuroendocrine carcinomas: pathogenesis, pathology and behavior. World J Surg. 1996;20:168-172.
42. Bordi C, Corleto VD, Azzoni C, et al. The antral mucosa as a new site for endocrine tumors in multiple endocrine neoplasia type 1 and Zollinger-Ellison syndromes. J Clin Endocrinol Metab. 2001;86:2236-2242.
43. Lin PW, Lin YJ. Prospective randomized comparison between pylorus-preserving and standard pancreatoduodenectomy. Br J Surg. 1999;86:603-607.
44. Muller MW, Friess H, Berger HG, et al. Gastric emptying following pylorus-preserving Whipple and duodenum-preserving pancreatic head resection in patients with chronic pancreatitis. Am J Surg. 1997;173:257-263.
45. Proye C, Pattou F, Carnaille B, et al. Intraoperative gastrin measurement during surgical management of patients with gastrinomas: experience with 20 cases. World J Surg. 1998;22:643-649.
46. Kato M, Imamura M, Hosotani R, et al. Curative resection of microgastrinomas based on the intraoperative secretin test. World J Surg. 2000;24:1425-1430.